Back
GlycoMimetics Vs. Cidara Therapeutics Industry Stock Comparison
Buy
71
GLYC
GlycoMimetics
Last Price:
0.41
Seasonality Move:
49.38%
Buy
62
CDTX
Cidara Therapeutics
Last Price:
14.66
Seasonality Move:
7.85%
Buy
71
GlycoMimetics (GLYC)
is a Buy
Is GlycoMimetics a Buy, Sell or Hold?
- The current GlycoMimetics [GLYC] share price is $0.40. The Score for GLYC is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- GLYC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
- The current Cidara Therapeutics [CDTX] share price is $13.94. The Score for CDTX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- CDTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GLYC Stock Price Chart
What is GlycoMimetics's stock price today?
-
The GlycoMimetics share price today is $0.40
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GLYC is experiencing slight selling pressure.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $13.94
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
GLYC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 65.14 | Buy |
| Chaikin Money Flow: | -142211 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.15 - 0.41) | Buy |
| Bollinger Bands (100): | (0.14 - 0.32) | Buy |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.62 | Buy |
| Relative Strength Index (14 RSI): | 71.09 | Buy |
| Chaikin Money Flow: | 22295 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.97 - 13.37) | Buy |
| Bollinger Bands (100): | (11.04 - 12.84) | Buy |
GLYC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.4 | Sell |
| 20-day SMA: | 0.31 | Buy |
| 50-day SMA: | 0.22 | Buy |
| 200-day SMA: | 1.06 | Sell |
| 8-day EMA: | 0.4 | Buy |
| 20-day EMA: | 0.34 | Buy |
| 50-day EMA: | 0.27 | Buy |
| 200-day EMA: | 0.76 | Sell |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.37 | Buy |
| 20-day SMA: | 12.59 | Buy |
| 50-day SMA: | 11.68 | Buy |
| 200-day SMA: | 12.96 | Buy |
| 8-day EMA: | 13.38 | Buy |
| 20-day EMA: | 12.73 | Buy |
| 50-day EMA: | 12.15 | Buy |
| 200-day EMA: | 13.17 | Buy |
GlycoMimetics Earnings Growth & GLYC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.01 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.97 per share, a decrease next quarter of $0.00 per share, a decrease this year of $18.96 per share, and an increase next year of $15.14 per share.
GlycoMimetics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||